Maze Therapeutics

📍 South San Francisco, United States🗓 Founded 2018👥 121 employees💰 Last funded 2022
Biotechnology Research🌐 mazetx.com
Website LinkedIn
Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas have enabled us to decode the mysteries of genetic modifiers in a range of severe diseases, which we aim to turn into medicines that mimic protective mutations. We have assembled a world-class team that we need to realize this vision, including creative scientific pioneers in genetics, experienced company builders, and biotech industry leaders.
4
Total investors
2
Early stage
2
Mid stage
0
Late stage
2018
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2018–2022 · investors recorded per year
20181201912021120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Maze Therapeutics?
Maze Therapeutics has 4 investors on record on gritt.io, including 2 early-stage backers, 2 mid-stage.
When did Maze Therapeutics last raise funding?
The most recent investment in Maze Therapeutics recorded on gritt.io was in 2022.
When was Maze Therapeutics founded?
Maze Therapeutics was founded in 2018.
What industry is Maze Therapeutics in?
Maze Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Maze Therapeutics based?
Maze Therapeutics is headquartered in South San Francisco, United States.